IHL has been accumulated all week with the same trading pattern,...

IHL has been accumulated all week with the same trading pattern, soak all the loose selling, test price levels and close well. Absolute textbook and we know there’s a new group getting involved so perhaps we are witnessing their inaugural buying.

COVID is arguably the most topical issue on the globe today and ARDS is the single largest cause of mortality. IHL is conducting the second round of clinical trials now with results due soon. Any positive result and this will launch IMO. It won’t matter if the US President is Trump or Biden, ARDS is a massive unmet need.

It’s also interesting to read Resmed’s results in context with the OSA clinical trial. Resmed is absolutely flying and IHL only needs a small percentage of this market to be worth many multiples of the current price. Exciting times.